Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
The insulin-like growth factor I receptor (IGF-IR) has been implicated in the etiology of breast cancer. Overexpression of the IGF-IR gene is a typical feature of most primary breast cancers, whereas low IGF-IR levels are seen at advanced stages. Hence, evaluation of IGF-IR levels might be important...
Main Authors: | Sarfstein, Rive, Belfiore, Antonino, Werner, Haim |
---|---|
Format: | Online |
Language: | English |
Published: |
Molecular Diversity Preservation International (MDPI)
2010
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835077/ |
Similar Items
-
Werner et al. Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
by: Sarfstein, Rive, et al.
Published: (2010) -
Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells
by: Weinstein, Doron, et al.
Published: (2014) -
The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches
by: Bruchim, Ilan, et al.
Published: (2014) -
Interaction between IGF-IR and ER Induced by E2 and IGF-I
by: Yu, Zhenghong, et al.
Published: (2013) -
The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway
by: Sarfstein, Rive, et al.
Published: (2011)